Emergent Biosolutions (EBS) Issues Q3 Miss
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $5.68 -5.33%
Revenue Growth %: -45.6%
Financial Fact:
Provision for (benefit from) income taxes: 13.17M
Today's EPS Names:
SUNB, CULP, KFY, More
Revenue Growth %: -45.6%
Financial Fact:
Provision for (benefit from) income taxes: 13.17M
Today's EPS Names:
SUNB, CULP, KFY, More
Join SI Premium – FREE
Emergent Biosolutions (NYSE: EBS) reported Q3 EPS of $0.04, $0.06 worse than the analyst estimate of $0.10. Revenue for the quarter came in at $58.8 million versus the consensus estimate of $63.59 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cooper Cos. (COO) Tops Q3 EPS by 3c, Offers Guidance
- Core & Main, Inc (CNM) Tops Q3 EPS by 2c ; Offers Guidance
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
